Many metabolic disorders such as obesity, dyslipidemia, diabetes, bone disorders, hepatic steatosis and inflammatory bowel disease are linked directly or indirectly with anomalous expression and unwarranted activation or repression of PXR depending on the cellular microenvironment and tissue-type7. This evidence concerns the gene NR1I2 and metabolic disease.